Home
Browse by Topic
Issues
Online First
Latest Issue
Issue Archive
Special Issues
PSS Guide
Index
Introduction
2023 Spotlight
Special Series
Conference Correspondent
Monthly Minutes
Gastrointestinal Cancer
Lung Cancer
Multiple Myeloma
Women's Health
Multimedia
All Videos
Interview with the Innovators
Rapid Reactions
Webinars
Subscribe
Home
Browse by Topic
Issues
Online First
Latest Issue
Issue Archive
Special Issues
PSS Guide
Index
Introduction
2023 Spotlight
Special Series
Conference Correspondent
Monthly Minutes
Gastrointestinal Cancer
Lung Cancer
Multiple Myeloma
Women's Health
Multimedia
All Videos
Interview with the Innovators
Rapid Reactions
Webinars
Subscribe
October 2016, Vol 6, No 10
Tecentriq (Atezolizumab) First PD-L1 Inhibitor Approved for Patients with Advanced or Metastatic Urothelial Carcinoma
By
Lisa A. Raedler, PhD, RPh
Drug Updates
October 2016, Vol 6, No 10
Read More ›
Page 2 of 2
1
2
Home
About
Press Releases
Contact Us
Subscribe
© Amplity Health. All Rights Reserved.
Privacy Policy.
